Glaukos downgraded to Underweight from Equal Weight at Morgan Stanley

Morgan Stanley analyst Patrick Wood downgraded Glaukos (GKOS) to Underweight from Equal Weight with a $120 price target While the firm thinks iDose is “a great product with a long-term trajectory,” it is struggling to see relative upside from here versus others stocks based on the current valuation. While there are also some “great assets in the pipeline,” these are some time out, the analyst added.